These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 4763134)

  • 1. [Coronary therapy in geriatrics].
    Grübl M; Klein K; Siedek H
    Wien Med Wochenschr; 1973 Dec; 123(50):741-5. PubMed ID: 4763134
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coronary therapy with Nitro-Sandolanid].
    Toker Y
    Munch Med Wochenschr; 1970 Apr; 112(17):809-12. PubMed ID: 5467991
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical use of a combination of butydrine and pentaerythrol in coronary insufficiency].
    Ballerini A
    Minerva Cardioangiol; 1971 May; 19(5):272-6. PubMed ID: 4397515
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences with a combined glycoside-nitrite treatment in chronic coronary insufficiency].
    Wick T
    Med Welt; 1969 Oct; 42():2327-30. PubMed ID: 5355678
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combination therapy of angina pectoris vera with coronary active substances and Faustan].
    Nossing R; Gruber G; Schmidt P
    Z Arztl Fortbild (Jena); 1971 Jun; 65(12):589-91. PubMed ID: 5000186
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy with pentaerithrityltetranitrate (PETN). Established effectiveness, once again on trial].
    MMW Fortschr Med; 2011 Feb; 153(7):44-5. PubMed ID: 21648143
    [No Abstract]   [Full Text] [Related]  

  • 7. New dimension in angina pectoris therapy.
    Russek HI
    Geriatrics; 1969 Mar; 24(3):81-95. PubMed ID: 4885554
    [No Abstract]   [Full Text] [Related]  

  • 8. Exercise tolerance in patients with angina pectoris: daily variation and effect of pentaerythritol tetranitrate.
    Dagenais GR; Mason RE; Friesinger GC; Wender C; Ross RS
    Johns Hopkins Med J; 1969 Dec; 125(6):301-11. PubMed ID: 4905736
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of coronary insufficiency with a combination of 2 nitro-derivatives. Controlled pluricentric clinical trial].
    Di Prisco AU; Vaccari GL; Soro A; Mora A
    Minerva Med; 1975 Feb; 66(12):551-61. PubMed ID: 1113905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coronary disease. Therapeutic results in 2,841 ambulatory patients].
    Deibert K; Ihm P
    ZFA (Stuttgart); 1979 May; 55(14):902-8. PubMed ID: 452663
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-anginal activity of a beta-adrenergic blocking agent, butydrine, alone and in association with pentaerythritol tetranitrate, in the aged].
    Gatti A; Scotti G
    Clin Ter; 1967 May; 41(4):363-74. PubMed ID: 5614306
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical data on 20 patients treated with the association of butydrine and pentaerythritol tetranitrate].
    Rossi PL; Guarraggi A; Anfossi F
    Clin Ter; 1971 May; 57(4):345-50. PubMed ID: 5110948
    [No Abstract]   [Full Text] [Related]  

  • 13. [The drug therapy effect on functional and organic stenocardias].
    Gill E
    Med Klin; 1966 Aug; 61(32):1258-60. PubMed ID: 4870033
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapeutic possibilities in coronary disease].
    Zoli I; Baroncini S; Cornia GL; Donato S; Minore G; Pigini G; Pretolani E
    Minerva Med; 1973 Nov; 64(84):4445-57. PubMed ID: 4272415
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy and prevention of ischemic heart diseases].
    Gill E
    Z Allgemeinmed; 1973 Oct; 49(28):1354-6. PubMed ID: 4756675
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical results of the use of a new drug association in heart diseases].
    Chierici F; Artuso P; Suriani L
    Clin Ter; 1970 Feb; 52(3):219-57. PubMed ID: 5419244
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experimentation with a combination of a beta-blocking agent and a nitro derivative in the prevention of anginous crises and in the basic treatment of coronary insufficiency].
    Borroni G
    Clin Ter; 1970 May; 53(3):247-58. PubMed ID: 4393972
    [No Abstract]   [Full Text] [Related]  

  • 18. [A new 2-phase coronary agent for the treatment of angina pectoris due to coronary disease].
    Gill E
    Med Welt; 1978 Mar; 29(10):408-11. PubMed ID: 416316
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug therapy of coronary and myocardial insufficiency].
    Krüger K
    Ther Ggw; 1974 Apr; 113(4):584 passim. PubMed ID: 4832533
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of combination therapy of pentalong (PETN) with obsidan (propranolol) in patients with coronary insufficiency].
    Gruber G; Hambsch K
    Z Arztl Fortbild (Jena); 1977 Feb; 71(4):167-71. PubMed ID: 868090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.